Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing oxygen-containing organic compound
Reexamination Certificate
2000-05-22
2002-10-29
Saucier, Sandra E. (Department: 1651)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing oxygen-containing organic compound
C435S822000
Reexamination Certificate
active
06472188
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to a method for producing hydroxycarboxylic acid monomers (mostly optically active in (R)-(−)-configuration) by auto-degradation of polyhydroxyalkanoates (PHAs). In particular, the present invention relates to a method for producing hydroxycarboxylic acid monomers comprising the steps of: (a) synthesizing and accumulating PHAs by culturing various microorganisms; and (b) preparing optically active (R)-(−)-hydroxycarboxylic acids, which are monomers of PHAs, by auto-degradation of PHAs by putting the cells containing PHAs in a degradation solution such as water, salt solution, mixture of water and organic solvents, and buffer solution. The method of the present invention also includes further the separation process for the separation of the prepared (R)-(−)-hydroxycarboxylic acids, if they exist as a mixture of two or more (R)-(−)-hydroxycarboxylic acids, using liquid chromatography (LC) or high performance liquid chromatography (HPLC), and also includes further the purification process for the removal of impurities from the purely-separated (R)-(−)-hydroxycarboxylic acids by organic solvent extraction and the powder-making process of the purified (R)-(−)-hydroxycarboxylic acids.
BACKGROUND OF THE INVENTION
(R)-(−)-3-hydroxycarboxylic acid can be widely used as a chiral precursor for several reasons as follows: it contains two functional groups, hydroxyl-group and carboxyl-group; the functional groups are convenient to modify; and a new chiral center can be introduced. And (R)-(−)-3-hydroxycarboxylic acid can be widely used as a precursor for synthesizing antibiotics, vitamins, aromatics, pheromones and the like; as a material for developing non-peptide ligand used in drug design; as a precursor for developing new drug; and especially as a precursor of carbapenem antibiotics, which has recently been drawing much attention to replace &bgr;-lactam antibiotics such as penicillin (Scott, In: Asymmetric Synthesis, Morrison and Scott, Eds., Academic Press Inc., Orlando, Fla., 1984). In addition, it was reported that (+)-thienamycin could be synthesized from methyl-(R)-(−)-3-hydroxybutyrate (Chiba and Nakai,
Chem,. Lett.,
651-654, 1985; Seebach and Zuger,
Helvetica Chim. Acta,
65: 495-503, 1982)
Presently, (R)-(−)-3-hydroxycarboxylic acid is mainly produced by the following methods: oxidation of aliphatic glycol by fermentation process (Harada and Hirayashi,
Agric. Biol. Chem.,
32: 1175, 1968); (R)-(−)-&bgr;-hydroxylation of carboxylic acid using microorganisms (Hasegawa et al.,
J. Ferment. Technol.,
60: 501, 1982); and hydrogenation of &bgr;-diketone using chiral catalyst (Noyori et al.,
J. Am. Chrem. Soc.,
109: 5856, 1987; Brussel et al., WO97/14500A1, 1997).
Polyhydroxyalkanoates (PHAs) are a carbon and/or energy storage material synthesized and accumulated in numerous microorganisms (Anderson and Dawes,
Microbiol. Rev.,
54: 450-472, 1990). More than 120 kinds of monomers have been found to be the constituents of PHAs, which can vary depending on the cultured microorganisms, chemical substrate or cosubstrate used, and culture conditions (Lee,
Biotechnol. Bioeng.,
49: 1-14, 1996; Steinbuchel and Valentin,
FEMS Microbiol. Lett.,
128: 219-228, 1995). Optically-pure (R)-(−)-hydroxycarboxylic acids may be easily prepared by degrading biosynthesized PHAs since the monomer units of biosynthesized PHAs are composed of monomers all in (R)-(−)-configuration, if the monomer has chiral center on the carbon possessing hydroxyl group, due to the optical specificity of biosynthetic enzymes. A method for producing (R)-(−)-3-hydroxyburyric acid and (R)-(−)-3-hydroxyvaleric acid from poly-(R)-(−)-3-hydroxybutyrate (PHB) or poly-(R)-(−)-3-hydroxybutyrate-co-(R)-(−)-3-hydroxyvalerate (PHB/V) by chemical degradation was reported (Seebach et al.,
Org. Synth.,
71: 39-47, 1992; Seebach and Zuger,
Helvetica Chim. Acta,
65: 495-503, 1982; Pennetreau, US005107016A, 1992; Pennetreau, EP0377260A1, 1989).
However, in the above method of producing (R)-(−)-3-hydroxybutyric acid and (R)-(−)-3-hydroxyvaleric acid by chemical degradation, organic solvents were used in large amounts, and the production efficiency was rather low due to complicated processes. Therefore, a new method for producing optically active hydroxycarboxylic acid, which can solve the above problem, is highly required in this field.
Very recently, a method for producing (R)-(−)-3-hydroxybutyric acid by microorganisms has been reported (Akira and Tatsuhiko, JP9-234091, 1997). This method was based on the simple obvious assumption that some microorganisms which accumulate poly-(R)-(−)-3-hydroxybutyrate (PHB) would also be able to produce its monomer, (R)-(−)-3-hydroxybutyric acid. They screened for micrcorgarisms that produce (R)-(−)-3-hydroxybutyric acid, and found that Pseudomonas sp., Burkholderia sp. and
Alcaligenes eutrophus
were able to produce (R)-(−)-3-hydroxybutyric acid. Here, it should be noted that
Alcaligenes eutrophus
has recently been renamed as
Ralstonia eutropha
, and therefore, does not belong to the family of Alcaligenes anymore (Yabuuchi et al.,
Microbiol. Immunol.,
39: 897-904, 1995). In the above method, microorganisms were cultivated for several days (4-7 days), and then transferred to potassium phosphate buffer solution for the production of (R)-(−)-3-hydroxybutyric acid. The monomer yields were very low at 2-8%. Furthermore, production of only (R)-(−)-3-hydroxybutyric acid, but not other (R)-(−)-hydroxycarboxylic acids, was reported. Since the monomer yields were extremely low and it took several days resulting in low productivity (defined as gram product produced per unit volume per unit time), the above method is not suitable for industrial applications.
PHAs are synthesized and accumulated inside the cells usually when one of the growth factors, such as nitrogen, phosphorus, oxygen, potassium and sulfur, is limiting while carbon source is in excess (Anderson and Dawes,
Microbiol. Rev.,
54: 450-472, 1990). Thus, if the limiting growth factor is supplied again, cells degrade the accumulated PHAs and grow.
All microorganisms that synthesize PHAs contain intracellular PHA depolymerase as well as PHA biosynthesis enzymes. Intracellular PHA depolymerase is known to exist in two states, soluble form and attached form to PHA granules (Merrick and Dourdoroff,
J. Bacteriol.,
88: 60-71, 1964; Merrick et al.,
J. Bacteriol.,
89: 234-239, 1965; Merrick and Yu,
Biochem.,
5: 3563-3568, 1966; Griebel et al.,
Biochemn.,
7: 3676-3681, 1968; Griebel and Merrick,
J. Bacteriol.,
108: 782-789, 1971; Anderson and Dawes,
Microbiol. Rev.,
54: 450-472, 1990). Merrick and Doudoroff (
J. Bacteriol.
88: 60-71, 1964) showed that native poly-(R)-(−)-3-hydroxybutyrate (PHB) granules, but not the solvent extracted PHB granules, could be depolymerized by an intracellular depolymerase system. They demonstrated that the PHB granules accumulated in
Bacillus megaterium
could be hydrolyzed to (R)-(−)-3-hydroxybutyric acid by a crude enzyme fraction of PHB-depleted cells of
Rhodospirillum rubrum
. Furthermore, Hippe and Schlegel (
Arch. Mikrobiol.
56: 278-299, 1967) reported that the soluble depolymerase from Alcaligenes (
Hydrogenomonas
) spp. could degrade native PHB to give (R)-(−)-3-hydroxybutyric acid. These early studies clearly demonstrated that cells possess intracellular PHA depolymerases, and can degrade PHA into monomers. However, isolation of native (amorphous) PHA granules is not only complicated but also expensive in large scale. Furthermore, isolation of intracellular depolymerase for the depolymerization of PHAs is also cumbersome and expensive. If crude cell extract containing intracellular PHA depolymerase is used for degradation of PHAs into monomers, there is a significant problem of product purification due to the contamination by the components in the cru
Lee Sang Yup
Lee Young
Wang Fulai
Afremova Vera
Bachman & LaPointe P.C.
ChiroBio Inc.
Saucier Sandra E.
LandOfFree
Method for producing hydroxycarboxylic acids by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for producing hydroxycarboxylic acids by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for producing hydroxycarboxylic acids by... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2998445